| UniProt ID | LIFR_MOUSE | |
|---|---|---|
| UniProt AC | P42703 | |
| Protein Name | Leukemia inhibitory factor receptor | |
| Gene Name | Lifr | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 1092 | |
| Subcellular Localization |
Isoform 1: Cell membrane Single-pass type I membrane protein. Isoform 2: Secreted. |
|
| Protein Description | Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells.. | |
| Protein Sequence | MAAYSWWRQPSWMVDNKRSRMTPNLPWLLSALTLLHLTMHANGLKRGVQDLKCTTNNMRVWDCTWPAPLGVSPGTVKDICIKDRFHSCHPLETTNVKIPALSPGDHEVTINYLNGFQSKFTLNEKDVSLIPETPEILDLSADFFTSSLLLKWNDRGSALPHPSNATWEIKVLQNPRTEPVALVLLNTMLSGKDTVQHWNWTSDLPLQCATHSVSIRWHIDSPHFSGYKEWSDWSPLKNISWIRNTETNVFPQDKVVLAGSNMTICCMSPTKVLSGQIGNTLRPLIHLYGQTVAIHILNIPVSENSGTNIIFITDDDVYGTVVFAGYPPDVPQKLSCETHDLKEIICSWNPGRITGLVGPRNTEYTLFESISGKSAVFHRIEGLTNETYRLGVQMHPGQEIHNFTLTGRNPLGQAQSAVVINVTERVAPHDPTSLKVKDINSTVVTFSWYLPGNFTKINLLCQIEICKANSKKEVRNATIRGAEDSTYHVAVDKLNPYTAYTFRVRCSSKTFWKWSRWSDEKRHLTTEATPSKGPDTWREWSSDGKNLIVYWKPLPINEANGKILSYNVSCSLNEETQSVLEIFDPQHRAEIQLSKNDYIISVVARNSAGSSPPSKIASMEIPNDDITVEQAVGLGNRIFLTWRHDPNMTCDYVIKWCNSSRSEPCLLDWRKVPSNSTETVIESDQFQPGVRYNFYLYGCTNQGYQLLRSIIGYVEELAPIVAPNFTVEDTSADSILVKWDDIPVEELRGFLRGYLFYFQKGERDTPKTRSLEPHHSDIKLKNITDISQKTLRIADLQGKTSYHLVLRAYTHGGLGPEKSMFVVTKENSVGLIIAILIPVAVAVIVGVVTSILCYRKREWIKETFYPDIPNPENCKALQFQKSVCEGSNALKTLEMNPCTPNNVEVLESRSIVPKIEDTEIISPVAERPGERSEVDPENHVVVSYCPPIIEEEITNPAADEVGGASQVVYIDVQSMYQPQAKAEEEQDVDPVVVAGYKPQMRLPISPAVEDTAAEDEEGKTAGYRPQANVNTWNLVSPDSPRSTDSNNEVVSFGSPCSINSRQFLIPPKDEDSPKSNGGGWSFTNFFQNKPND | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 164 | N-linked_Glycosylation | SALPHPSNATWEIKV CCCCCCCCCCEEEEE | 45.93 | 17652170 | |
| 177 | Phosphorylation | KVLQNPRTEPVALVL EEECCCCCCCCEEHH | 45.99 | - | |
| 187 | Phosphorylation | VALVLLNTMLSGKDT CEEHHHHHHHCCCCC | 21.32 | - | |
| 199 | N-linked_Glycosylation | KDTVQHWNWTSDLPL CCCCCCCCCCCCCCC | 29.98 | 17652170 | |
| 214 | Phosphorylation | QCATHSVSIRWHIDS EEEECEEEEEEEECC | 14.95 | 25159016 | |
| 238 | N-linked_Glycosylation | SDWSPLKNISWIRNT CCCCCCCCEEEECCC | 41.01 | 17652170 | |
| 261 | N-linked_Glycosylation | KVVLAGSNMTICCMS CEEEECCCEEEEEEC | 30.60 | 17652170 | |
| 362 | Phosphorylation | GLVGPRNTEYTLFES EEECCCCCEEEEEEE | 31.48 | 25777480 | |
| 364 | Phosphorylation | VGPRNTEYTLFESIS ECCCCCEEEEEEECC | 13.50 | 25777480 | |
| 365 | Phosphorylation | GPRNTEYTLFESISG CCCCCEEEEEEECCC | 20.81 | 25777480 | |
| 369 | Phosphorylation | TEYTLFESISGKSAV CEEEEEEECCCCCHH | 18.08 | 25777480 | |
| 371 | Phosphorylation | YTLFESISGKSAVFH EEEEEECCCCCHHHH | 49.82 | 25777480 | |
| 374 | Phosphorylation | FESISGKSAVFHRIE EEECCCCCHHHHEEE | 32.94 | 25777480 | |
| 385 | N-linked_Glycosylation | HRIEGLTNETYRLGV HEEECCCCCCEEEEE | 44.66 | 17330941 | |
| 402 | N-linked_Glycosylation | HPGQEIHNFTLTGRN CCCCEEECEEEECCC | 36.94 | 17652170 | |
| 421 | N-linked_Glycosylation | AQSAVVINVTERVAP CCEEEEEEECCCCCC | 24.05 | 17652170 | |
| 440 | N-linked_Glycosylation | SLKVKDINSTVVTFS CCEEECCCCEEEEEE | 41.59 | 17652170 | |
| 453 | N-linked_Glycosylation | FSWYLPGNFTKINLL EEEECCCCCCCEEEE | 39.20 | 17652170 | |
| 476 | N-linked_Glycosylation | NSKKEVRNATIRGAE CCCHHHHHCEECCCC | 46.76 | - | |
| 505 | Methylation | TAYTFRVRCSSKTFW CEEEEEEEECCCCCE | 15.44 | 18965505 | |
| 505 | Dimethylation | TAYTFRVRCSSKTFW CEEEEEEEECCCCCE | 15.44 | - | |
| 567 | N-linked_Glycosylation | NGKILSYNVSCSLNE CCEEEEEEEEECCCH | 18.82 | - | |
| 611 | Phosphorylation | ARNSAGSSPPSKIAS EECCCCCCCCHHHCC | 39.65 | 26026062 | |
| 647 | N-linked_Glycosylation | LTWRHDPNMTCDYVI EEECCCCCCCCCEEE | 44.44 | - | |
| 658 | N-linked_Glycosylation | DYVIKWCNSSRSEPC CEEEEECCCCCCCCE | 41.74 | 17330941 | |
| 675 | N-linked_Glycosylation | DWRKVPSNSTETVIE ECEECCCCCCCEEEE | 47.05 | 16944957 | |
| 724 | N-linked_Glycosylation | LAPIVAPNFTVEDTS HCCCCCCCCEECCCC | 35.17 | - | |
| 782 | N-linked_Glycosylation | HSDIKLKNITDISQK CCCCCCCCCCCCCCC | 53.48 | - | |
| 784 | Phosphorylation | DIKLKNITDISQKTL CCCCCCCCCCCCCEE | 36.35 | 23375375 | |
| 787 | Phosphorylation | LKNITDISQKTLRIA CCCCCCCCCCEEEEE | 28.56 | 23375375 | |
| 861 | Ubiquitination | YRKREWIKETFYPDI HHHHHHHHHHCCCCC | 52.34 | - | |
| 881 | Ubiquitination | CKALQFQKSVCEGSN CCHHHHHHHHHCCCC | 46.26 | 22790023 | |
| 882 | Phosphorylation | KALQFQKSVCEGSNA CHHHHHHHHHCCCCC | 22.63 | 25521595 | |
| 918 | Phosphorylation | IVPKIEDTEIISPVA CCCCCCCCEEEECCC | 19.12 | 29899451 | |
| 922 | Phosphorylation | IEDTEIISPVAERPG CCCCEEEECCCCCCC | 20.98 | 22817900 | |
| 1039 | Phosphorylation | WNLVSPDSPRSTDSN EEEECCCCCCCCCCC | 26.12 | 21082442 | |
| 1054 | Phosphorylation | NEVVSFGSPCSINSR CCEEEECCCCEECCC | 22.26 | 25162660 | |
| 1072 | Phosphorylation | IPPKDEDSPKSNGGG CCCCCCCCCCCCCCC | 31.98 | 23140645 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LIFR_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LIFR_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LIFR_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of LIFR_MOUSE !! | ||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "An unusual cytokine:Ig-domain interaction revealed in the crystalstructure of leukemia inhibitory factor (LIF) in complex with the LIFreceptor."; Huyton T., Zhang J.G., Luo C.S., Lou M.Z., Hilton D.J., Nicola N.A.,Garrett T.P.; Proc. Natl. Acad. Sci. U.S.A. 104:12737-12742(2007). Cited for: X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) OF 49-529 IN COMPLEX WITH HUMANLIF, DISULFIDE BOND, AND GLYCOSYLATION AT ASN-164; ASN-199; ASN-238;ASN-261; ASN-385; ASN-402; ASN-421; ASN-440 AND ASN-453. | |
| "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-385, AND MASSSPECTROMETRY. | |
| "Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides."; Bernhard O.K., Kapp E.A., Simpson R.J.; J. Proteome Res. 6:987-995(2007). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-385 AND ASN-658, AND MASSSPECTROMETRY. | |
| "Proteome-wide characterization of N-glycosylation events by diagonalchromatography."; Ghesquiere B., Van Damme J., Martens L., Vandekerckhove J.,Gevaert K.; J. Proteome Res. 5:2438-2447(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-385; ASN-402 AND ASN-675,AND MASS SPECTROMETRY. | |